The terminal sequence of complement plays an essential role in antibody- mediated renal cell apoptosis

Journal of the American Society of Nephrology

Volumn 10, Issue 6, 1999, Pages 1242-1252

  Sato, Toshinobu ^c   Van Dixhoorn, Mieneke G A ^c   Prins, Frans A ^c   Mooney, Andrew ^a   Verhagen, Nicole ^c   Muizert, Yvonne ^c   Savill, John ^a   Van Es, Leendert A ^c   Daha, Mohamed R ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; DNA NUCLEOTIDYLEXOTRANSFERASE; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL POPULATION; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; COMPLEMENT DEFICIENCY; COMPLEMENT DEPOSITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; MESANGIUM CELL; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; RAT;

EID: 0032994258     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87: 847-858, 1991
2. Floege J, Eng E, Young BA, Alpers CE, Barrrett TB, Bowen-Pope DF, Johnson RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation. J Clin Invest 92: 2952-2962, 1993
3. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy-1.1 antibodies. Lab Invest 55: 680-687, 1986
4. Yamamoto T, Wilson CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 138: 3758-3765, 1987
5. Bachgus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Acute glomerulonephritis after intravenous injection of monoclonal anti-thymocyte antibodies in the rat. Immunol Lett 12: 109-113, 1986
6. Nishikage H, Baranyi L, Okada H, Okada N, Isobe K, Nomura A, Yoshida F, Matsuo S: The role of a complement regulatory protein in rat mesangial glomerulonephritis. J Am Soc Nephrol 6: 234-242, 1995
7. van Dixhoorn MGA, Salazar-Exaire D, Sato T, Daha MR, Quigg RJ, Bruijn JA, Couser WG, de Heer E: Anti-vitronectin antibodies enhance anti-Thy-1 induced proteinuria in PVG/c, but not in Wistar rats. J Am Soc Nephrol 9: 994-1007, 1998
8. Duke RC, Chervenak R, Cohen JJ: Endogenous endonuclease-induced DNA fragmentation: An early event in cell mediated cytolysis. Proc Natl Acad Sci USA 80: 6361-6365, 1983
9. Duvall E, Wyllie AH: Death and the cell. Immunol Today 7: 115-118, 1986
10. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94: 2105-2116, 1994
11. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Reactive oxygen species induce apoptosis in cultured human mesangial cells. J Am Soc Nephrol 7: 2357-2363, 1996
12. Sandau K, Pfeilschifter J, Brune B: Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int 52: 378-386, 1997
13. Sato T, van Dixhoorn MGA, Schroeijers WEM, Huizinga TWJ, Reutelingsperger CPM, van Es LA, Daha MR: Apoptosis of cultured rat glomerular mesangial cells induced by IgG2a monoclonal anti-Thy-1 antibodies. Kidney Int 49: 403-412, 1996
14. Sato T, van Dixhoorn MGA, Schroeijers WEM, van Es LA, Daha MR: Efficient induction of apoptosis in cultured rat glomerular mesangial cells by dimeric monoclonal IgA anti-Thy-1 antibodies. Kidney Int 51: 173-181, 1997
15. Morita H, Isobe K, Cai Z, Miyazaki T, Matsumoto Y, Schinzato T, Yoshikai Y, Kimata K, Maeda K: Thy-1 antigen mediates apoptosis of rat glomerular cells in vitro and in vivo. Nephron 73: 293-298, 1996
16. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47: 114-121, 1995
17. Cattell V, LIanos E, Largen P, Cook T: Glomerular NO synthase activity in mesangial cell immune injury. Exp Nephrol 1: 36-40, 1993
18. Goto S, Yamamoto T, Feng L, Yaoita E, Hirose S, Fujinaka H, Kawasaki K, Hattori R, Yui Y, Wilson CB, Arakawa M, Kihara I: Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol 147: 1133-1141, 1995
19. Boyce NW, Tipping PG, Holdsworth SR: Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int 35: 778-782, 1989
20. Oberle GP, Niemeyer J, Thaiss F, Schoeppe W, Stahl RAF: Increased oxygen radical and eicosanoid formation in immunemediated mesangial cell injury. Kidney Int 42: 69-74, 1992
21. van Dixhoorn MGA, Timmerman JJ, van Gijlswijk-Janssen DJ, Muizert Y, Verweij C, Daha MR: Characterization of the complement C6 deficiency in a PVG/c rat strain. Clin Exp Immunol 109: 387-396, 1997
22. Mason DW, Williams AF: The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem J 187: 1-20, 1980
23. Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG: Transcellular transport and membrane insertion of the C5b-6 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143: 546-552, 1989
24. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35: 60-68, 1989
25. Dijkstra CD, Döpp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, ED3. Immunology 54: 589-599, 1985
26. Williams AF, Gralfre G, Milstein C: Analysis of cell surfaces by xenogenic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes. Cell 12: 663-673, 1977
27. Daha MR: Purification of complement. In: Complement: A Practical Approach, edited by Dodds AW, Sim RB, Oxford, United Kingdom, Oxford University Press, 1997, pp 121-133
28. Timmerman JJ, van Dixhoorn MGA, Schraa EO, van Gijlswijk-Janssen DJ, Muizert Y, van Es LA, Daha MR: Extrahepatic C6 is as effective as hepatic C6 in generation of C5b-9 in anti-Thy-1.1 nephritis. Kidney Int 51: 1788-1796, 1997
29. Leenaerts PL, Stad RK, Hall BM, van Damme BJ, van Renterghem Y, Daha MR: Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol 97: 478-484, 1994
30. Gavirieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992
31. Prins FA, Bruijn JA, de Heer E: Application in renal immunopathology of reflection contrast microscopy, a novel superior light microscopical technique. Kidney Int 49: 261-266, 1996
32. Falk RJ, Dalmasso AP, Kim Y, Tsai CH, Scheinman JI, Gewurz H, Michael AF: Neoantigen of polymerized ninth component of complement: Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 72: 560-573, 1983
33. Hinglais N, Kazatchkine MD, Bhakdi S, Appay MD, Mandet C, Grossetete J, Bariety J: Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int 30: 399-410, 1986
34. Yoshioka K, Takemura T, Akino N, Okada M, Yagi K, Maki S, Inai S, Akita H, Koitabashi Y, Takekoshi Y: IgA nephropathy in patients with congenital C9 deficiency. Kidney Int 42: 1253-1258, 1992
35. Brenchley PE, Coupes B, Short CD, O'Donoghue DJ, Ballardie FW, Mallick NP: Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 41: 933-937, 1992
36. Takemura T, Murakami K, Miyazato H, Yagi K, Yoshioka K: Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 48: 1886-1892, 1995
37. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 49: 103-111, 1996
38. Papadimitriou JC, Drachenberg CB, Shin ML, Trump BF: Ultrastructual studies of complement mediated cell death: A biological reaction model to plasma membrane injury. Virchows Arch 424: 677-685, 1994
39. Hueber AO, Raposo G, Pierres M, He HT: Thy-1 triggers mouse thymocyte apoptosis through a bcl-2-resistant mechanism. J Exp Med 179: 785-796, 1994
40. Fujita N, Kato Y, Naito M, Tsuruo T: A novel anti-Thy-1 (CD95) monoclonal antibody induces apoptosis in mouse malignant T-lymphoma cells in spite of inducing bcl-2 expression. Int J Cancer 66: 544-550, 1996
41. Narisawa-Saito M, Kimura S, Fujiwara N, Oite T, Shimoji K, Shimizu F: Thy-1 -mediated phosphatidylinositol turnover in cultured rat glomerular mesangial cell. J Cell Physiol 168: 705-710, 1996
42. 2+ -mediated endonuclease activation. Science 242: 256-259, 1988
43. Narisawa-Saito M, Yamanashi Y, Morioka T, Oite T, Shimizu F: Thy-1 molecule associated with protein tyrosine kinase in rat mesangial cells. Clin Exp Immunol 106: 86-90, 1996
44. Eischen CM, Dick CJ, Leibson PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153: 1947-1954, 1994
45. lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 δ chain, and induces apoptosis. J Immunol 158: 3189-3196, 1997
46. Carney DF, Thomas JL, Moon LS: Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J Immunol 145: 623-629, 1990
47. Korb LC, Ahearn JM: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J Immunol 158: 4525-4528, 1997
48. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 44: 1036-1047, 1993
49. Wu X, Dolecki GJ, Sherry B, Zagorski J, Lefkowith JB: Chemokines are expressed in a myeloid cell-dependent fashion and mediate distinct functions in immune complex glomerulonephritis in rat. J Immunol 158: 3917-3924, 1997
50. Hänsch GM, Seitz M, Betz M: Effect of the late complement components C5b-9 on human monocytes: Release of prostanoids, oxygen radical and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol 82: 317-320, 1987
51. Schönermark M, Deppisch R, Riedasch G, Rother K, Hänsch GM: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 96: 331-337, 1991
52. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77: 762-767, 1986
53. Marsden PA, Ballermann BJ: Tumor necrosis factor-a activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med 172: 1843-1852, 1990
54. Cook T, Ebrahim H, Eberhardt W, Pfeilschifter J, Cattell V: iNOS induction in Thy-1 glomerulonephritis [Abstract]. J Am Soc Nephrol 7: 1695, 1996
55. van Diemen-Steenvoorde R, Lambers A, van der Wal A, van Rooyen N, Dijkstra C, Hoedemaeker PJ, de Heer E: Macrophages are responsible for mesangial cell injury and extracellular matrix (ECM) expansion in anti-Thy-1 nephritis in rats [Abstract]. J Am Soc Nephrol 2: 585, 1991
56. Narita I, Border WA, Ketterler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 72: 17-24, 1995